Mevion Medical Systems
Private Company
Total funding raised: $70M
Overview
Mevion Medical Systems is a private medical device company specializing in compact proton therapy systems. Its flagship MEVION S250 Series is designed to reduce the size, complexity, and cost of proton therapy, making it a preferred choice for numerous leading cancer centers, including many NCI-Designated centers. The company has achieved significant commercial traction with multiple installations globally and has secured key regulatory clearances from the FDA and CE Marking for its latest S250-FIT system. Mevion's leadership combines deep industry experience with strong financial and entrepreneurial backgrounds, positioning the company to expand the adoption of proton therapy.
Technology Platform
Compact proton therapy system (MEVION S250 Series) featuring HYPERSCAN pencil beam scanning for intensity-modulated proton therapy (IMPT), designed for a small footprint, high reliability (97% uptime), and lower capital/operating costs.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Mevion competes in the proton therapy market against major players like Varian Medical Systems (Siemens Healthineers) and Ion Beam Applications (IBA), which offer both large-scale and compact systems. Its primary differentiation is its claimed leadership in compact systems, with a focus on smaller footprint, lower cost, and high uptime, which has garnered significant adoption among NCI-Designated Cancer Centers.